Convection-enhanced delivery for treatment of brain tumors (Q37030814)

17 August 2017

1 reference

title

Convection-enhanced delivery for treatment of brain tumors (English)

1 reference

convection-enhanced delivery

17 August 2017

main subject

0 references

author name string

Sherise D Ferguson

series ordinal

1

1 reference

17 August 2017

Kimberly Foster

series ordinal

2

1 reference

17 August 2017

Bakhtiar Yamini

series ordinal

3

1 reference

17 August 2017

publication date

1 December 2007

1 reference

Expert Review of Anticancer Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

12 Suppl

1 reference

17 August 2017

page(s)

S79-85

1 reference

Diagnosis and treatment of recurrent high-grade astrocytoma

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Magnetic resonance imaging and histopathology of cerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Junctions between intimately apposed cell membranes in the vertebrate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Convection-enhanced delivery in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Claudin-1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Convection-enhanced delivery of macromolecules in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Flexible versus rigid catheters for chronic administration of exogenous agents into central nervous system tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Convection-enhanced delivery of therapeutics for brain disease, and its optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Intracerebral clysis in a rat glioma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Intratumoral infusion of interleukin-1beta and interferon-gamma induces tumor invasion with macrophages and lymphocytes in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malig

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

(131)I-chTNT-1/B mAb: tumour necrosis therapy for malignant astrocytic glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.12S.S79

10.1586/14737140.7.12S.S79

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference